And this is why with the conversion of the unlisted oppies NEU will, most probably, be fully funded until into 2015.
A tight, well managed company that only burns a net $180k a month, but has numerous "blockbuster" products in trials and development.
It's hard to find fault with NEU. Products with huge potential funded by grants wherever possible (and the US Army, read US Government, to boot!!). Well managed from an operational/cash flow perspecive perspective. Low mkt cap. Increasingly tightly held register. Coming onto radar of broking community.
A hold if you are in already. A buy, imho, if you are still on the sidelines.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.93 |
Change
-0.360(2.08%) |
Mkt cap ! $2.133B | |||
| Open | High | Low | Value | Volume |
| $17.08 | $17.67 | $16.93 | $6.897M | 401.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2660 | $16.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.07 | 1994 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |